BEO
0.12
50%
KYN
0.03
-21.1%
CMO
0.005
25%
G11
0.2
-20%
EXT
0.005
25%
MQR
0.004
-20%
LIO
0.012
20%
DBO
0.014
-17.6%
PKO
0.012
20%
AM5
0.005
-16.7%
VR8
0.045
18.4%
CTQ
0.015
-16.7%
RWL
0.195
18.2%
MGU
0.005
-16.7%
1MC
0.033
17.9%
RVT
0.11
-15.4%
EM2
0.007
16.7%
RML
0.051
-15%
FEL
0.007
16.7%
NAG
0.013
-13.3%
IMM
0.051
15.9%
CAZ
0.02
-13%
M96
0.008
14.3%
CCR
0.14
-12.5%
YUG
0.049
14%
FCT
0.007
-12.5%
TAS
0.033
13.8%
KEY
0.105
-12.5%
SLD
0.455
13.8%
LIT
0.007
-12.5%
HT8
0.017
13.3%
OEL
0.007
-12.5%
RNV
0.077
13.2%
PLC
0.007
-12.5%
EGG
0.26
13%
X2M
0.007
-12.5%
LML
0.009
12.5%
ZEU
0.007
-12.5%
ADX
0.02
11.1%
AR1
0.072
-12.2%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Vitrafy Life Sciences (ASX:VFY): Lists on ASX

Vitrafy Life Sciences has listed on the ASX with a ticker code of VFY. The company has designed and developed an innovative cryopreservation solution, which has application across many uses in animal and human health. Having proven its technology, Vitrafy is now pursuing additional product development initiatives and collaboration agreements.

Website: https://vitrafy.com/
Board: Sonia Petering – Chair, Assoc Professor John McBain – Chair, Scientific Advisory Board and Non-Executive Director, Brent Owens – Deputy Chief Executive Officer, Co-Founder and Executive Director, Kate Munnings – Chief Executive Officer, Vaughan Webber – Non‑Executive Director
Management: Kate Munnings – Chief Executive Officer, Simon Martin – Chief Financial Officer
Media: The Stock Network Lel Smits